Back to EPRX

RAYMOND JAMES FINANCIAL INC → EPRX

RAYMOND JAMES FINANCIAL INC EPRX Position History

Eupraxia Pharmaceuticals Inc. • Healthcare

Quarters held
10
Latest value
$429K
Q3 2026
Peak value
$429K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$1K
Q3 2025$196K
Q4 2025$2K
Q4 2025$398K
Q1 2026$74K
Q1 2026$292K
Q2 2026$81K
Q2 2026$273K
Q3 2026$49K
Q3 2026$429K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$429K47.1K——
Q3 2026$49K5.3K——
Q2 2026$273K41.3K——
Q2 2026$81K12.2K——
Q1 2026$292K40.3K——
Q1 2026$74K10.2K——
Q4 2025$398K52.8K——
Q4 2025$2K220——
Q3 2025$196K33.2K——
Q3 2025$1K220——

Other funds holding EPRX

Other RAYMOND JAMES FINANCIAL INC positions

VGES

VANGUARD INDEX FDS

$19.3B
VGES

VANGUARD INDEX FDS

$18.6B
VGES

VANGUARD INDEX FDS

$16B
VGES

VANGUARD INDEX FDS

$15.9B
VGES

VANGUARD INDEX FDS

$15.1B
ETHA

ISHARES TR

$8.5B
ETHA

ISHARES TR

$8.5B
ETHA

ISHARES TR

$8.1B